This inventor holds 1 USPTO granted patent. Top assignee: Taizhou Enze Medical Center (Group). Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Xinli Mao in Medical Technology
Introduction
Xinli Mao is a notable inventor based in Taizhou, China. He has made significant contributions to the field of medical technology, particularly with his innovative designs in stent technology. His work has garnered attention for its potential to improve patient outcomes in gastrointestinal treatments.
Latest Patents
One of Xinli Mao's most recent patents is the fenestrated duodenal stent. This stent features a unique design that includes a stent body enclosed by a meshed sidewall. The stent body is open at both ends and hollow inside, which allows for effective functionality. It consists of a proximal support segment, a distal support segment, and an opening segment that connects the two. The proximal support segment is further divided into a front section, a middle section, and a rear section, each designed to enhance the stent's performance. The innovative structure of the stent aims to provide better support and flexibility for patients.
Career Highlights
Xinli Mao is currently associated with the Taizhou Enze Medical Center Group, where he continues to develop and refine medical devices. His work in this institution has allowed him to collaborate with other professionals in the field, contributing to advancements in medical technology.
Collaborations
Xinli Mao has worked alongside talented colleagues, including Liping Ye and Shenkang Zhou. Their collaborative efforts have fostered an environment of innovation and creativity, leading to the development of groundbreaking medical solutions.
Conclusion
Xinli Mao's contributions to medical technology, particularly through his fenestrated duodenal stent, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements that can significantly impact patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile